Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Journal of Neuro-Oncology|January 1, 1984
Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumorsD J Stewart, M T Richard, H Hugenholtz, et al.Veterinary and Comparative Oncology|June 19, 2023
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcomaTanya F Wright, Brigitte A Brisson, Catherine R Belanger, et al.Open Forum Infectious Diseases|November 3, 2018
The Facility-Level HIV Treatment Cascade: Using a Population Health Tool in Health Care Facilities to End the Epidemic in New York StateDaniel J Ikeda, Leah Hollander, Susan Weigl, et al.Journal of Thoracic Disease|September 28, 2019
Incidence and clinical relevance of non-small cell lung cancer lymph node micro-metastasis detected by staging endobronchial ultrasound-guided transbronchial needle aspirationAdam R Belanger, Johnathan Hollyfield, Gabriella Yacovone, et al.Frontiers in Microbiology|October 31, 2022
BosR: A novel biofilm-specific regulator in <i>Pseudomonas aeruginosa</i>Melanie Dostert, Corrie R Belanger, Lucas Pedraz, et al.Annals of the New York Academy of Sciences|January 1, 1976
Immunochemotherapy of lung cancerT H Stewart, A C Hollinshead, J E Harris, et al.Frontiers in Microbiology|December 12, 2022
Surviving the host: Microbial metabolic genes required for growth of <i>Pseudomonas aeruginosa</i> in physiologically-relevant conditionsCorrie R Belanger, Melanie Dostert, Travis M Blimkie, et al.Critical Reviews in Oncology/Hematology|June 22, 2001
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphomaG A Wiseman, C A White, R B Sparks, et al.European Journal of Nuclear Medicine|August 22, 2000
Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphomaG A Wiseman, C A White, M Stabin, et al.Diagnostic Microbiology and Infectious Disease|April 21, 2026
Performance evaluation of the COPAN Colibrí™ instrument for automated identification using the bruker MALDI-TOF Biotyper® and antimicrobial susceptibility testing with the bioMérieux VITEK®2Jasmine Ahmed-Bentley, Kim Sy, Colleen Fletcher, et al.Pageof 6